Single Ascending Dose Study of PRX002 in Healthy Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
This single ascending dose study is to determine safety, tolerability, pharmacokinetics and immunogenicity of PRX002 in approximately 40 healthy subjects.
Epistemonikos ID: adbaca2e1c18386fb1db09ffb571197236400e81
First added on: May 11, 2024